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Malassezia furfur isolates from diseased skin preferentially biosynthesize compounds 
which are among the most active known Aryl-hydrocarbon Receptor (AhR) inducers, 
such as indirubin, tryptanthrin, indolo[3,2-b]carbazole and 6-formylindolo[3,2-
b]carbazole. In our effort to study their production from Malassezia spp., we 
investigated the role of indole-3-carbaldehyde (I3A), the most abundant metabolite of 
Malassezia when grown on tryptophan agar, as a possible starting material for the 
biosynthesis of the alkaloids. Treatment of I3A with H2O2 and use of catalysts like 
diphenyldiselenide resulted in the simultaneous one-step transformation of I3A to 
indirubin and tryptanthrin in good yields. The same reaction was first applied on simple 
indole and then on substituted indoles and indole-3-carbaldehydes, leading to a series 
of mono- and bi-substituted indirubins and tryptanthrins bearing halogens, alkyl or 
carbomethoxy groups. Afterwards, they were evaluated for their A R agonist activity 
in recombinant human and mouse hepatoma cell lines containing  stably transfected 
AhR-response luciferase reporter gene. Among them, 3,9-dibromot yptanthrin was 
found to be equipotent to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as an AhR 
agonist and 3-bromotryptanthrin was 10-times more potent tha  TCDD in the human 
HG2L7.5c1 cell line.  In contrast, 3,9-dibromotryptanthrin and 3-bromotryptanthrin 
were ~4,000- and >10,000-times less potent than TCDD in the mouse H1L7.5c3 cell 
line, respectively, demonstrating that they are species-spcific AhR agonists. 
Involvement of the AhR in the action of 3-bromotryptanthrin was confirmed by the 
ability of the AhR antagonists CH223191 and SR1 to inhibit 3-bromotryptanthrin-
dependent reporter gene induction in human HG2L7.5c1 cells. In conclusion, I3A can 
be the starting material used by Malassezia for the productin of both indirubin and 
tryptanthrin through an oxidation mechanism and modification of these compounds can 







Malassezia yeasts are part of the human skin microbiota that can become 
pathogenic and cause serious infections such as seborrhoeic dermatitis, pytiriasis 
versicolor, dandruff and psoriasis.1 Extensive studies have revealed the preferential 
biosynthesis of indole derivatives by Malassezia furfur isolates from lessional skin 
which are among the most potent Aryl-hydrocarbon Receptor (AhR) activators known, 
e.g. indirubin, tryptanthrin, indolo[3,2-b]carbazole (ICZ) and 6-formylindolo[3,2-
b]carbazole (6-FICZ).2-4 Although the production of the above AhR activators seems 
to be a general characteristic of the genus, specific Malasezia pecies and strains are 
able to overproduce them and consequently their constant presence in the skin at 
elevated concentrations has been proposed to be implicated in he development of skin 
diseases.2, 3 However up today there is no available data about the biosynthetic origin 
of those compounds except that they are related with tryptophan.  
Having as ultimate target of future works the inhibition of their overproduction 
and possibly the inhibition of their toxic effects for skin, we considered as a very 
important first step to investigate the role of potential b osynthetic precursors and the 
chemical mechanism that could lead to their production, mimicking what is potentially 
happening with Malassezia.The first compound that was investigated as a possible 
starting material for the biosynthesis of the alkaloids was indolo-3-carbaldehyde, I3A 
(1), the most abundant metabolite of all studied Malassezia strains when cultured with 
L-tryptophan as single nitrogen source.5, 6  
During early trials, the treatment of I3A (1) with H2O2 and acetic acid resulted 
in intensively colored solutions, suggesting thus the formation of i digoids. The major 
product was indigo but other indole derivatives such as indirubin (2) could be detected 
in traces by NMR spectroscopy. Further trials under Baeyer-Villiger oxidation 
conditions led to increased yield of indirubin (2). This type of reaction is commonly 
used for the transformation of aromatic ketones and aldehydes to the corresponding 
esters7 but in this case it led to more complicated structures. For realizing this reaction 
we chose, among the available oxidants, hydrogen peroxide due to its eco-friendly 
nature, its natural presence and that exposure to H2O2 occurs in most human cells.8 We 
also investigated the use of a potential catalyst in order to promote the reaction and 
enhance the yield of the desirable compounds.  A thorough investigation of several 
parameters led to the discovery of a biomimetic reaction that can possibly explain the 




Complementary to this assumption is a recent publication that indicates the synthesis, 
from indole-3-acetaldehyde upon treatment with H2O2, of 6-FICZ, another Malassezia 
metabolite.9 Although we were unable to detect indole-3-acetaldehyde in the extracts 
of Malassezia species, it is biosynthetically a probable product of tryptophan 
metabolism.10 
At a next step, the above described reaction was applied to several substituted 
indolic monomers for the preparation of a series of new or known indirubin and 
tryptanthrin derivatives, having as target the investigation of the structure-activity 
relationships concerning the AhR activation. Finally, all the synthesized analogues 
were evaluated for their stimulate AhR-dependent gene expression, leading to the 
identification of some compounds with significantly increased potency and efficacy. 
 
EXPERIMENTAL PROCEDURES 
Materials and Equipment 
All the solvents used during the experimental procedure were of analytical grade 
or distilled. Aluminum and glass plates, covered with silicon di xide (Silica gel 60 F254) 
were used for TLC and preparative TLC respectively and the obtained chromatograms 
were observed in a CAMAG TLC Visualizer at 254 and 366 nm. All the one- and two-
dimensional NMR spectra of the purified compounds, as well as the calculations of the 
reaction yields, were acquired in a Bruker UltrashieldTM Plus 600MHz NMR. 
 
Initial methodology of the reaction on I3A (1) 
 0.34 mmol of I3A (1) were dissolved in 1.0 mL distilled DCM while 0.1 mL 
H2O2 10% and 0.05 mmol of (PhSe)2 were then added in the reaction mixture. The flask 
was covered with aluminum foil to prevent occurrence of anylight-induced side-
reactions and the solution was stirred for 1.5 hours at oom temperature (rt). Then, the 
same quantities of catalyst and oxidative reagent were added again and the reaction 
remained under mechanical stirring overnight at rt. After the formation of a dark-
colored solution, MeOH was added in the mixture and it was evporated to dryness. 
Then the crude mixture was submitted to column chromatography for the isolation of 
the produced compounds. 
 




 The modified protocol for the investigation of the above reaction was based on 
a method described by Santoro et al.11 0 4 mmol of I3A (1) or indole (8) were added to 
a mixture of 2.1 mL H2O2 6% and 0.7 mL acetonitrile containing a catalytic amount of 
(PhSe)2 (0.04 mmol). The reaction remained under mechanical stirring for 72h at 23°C. 
The precipitate was filtered, washed with water, then solubilized with THF, collected 
and evaporated to dryness. The isolation of the synthesized compounds 2 and 3 was 
performed with preparative TLC and their structure elucidation with NMR 
spectroscopy. 
 
Optimization of the reaction conditions 
 For the optimization of the reaction, numerous trials were performed by 
modifying and investigating parameters such as the oxidative means, the catalyst or the 
quantity of the reagents. These efforts were carried out in parallel, under the same 
environmental conditions and by modifying only one parameter at the time. In all cases 
the starting material was I3A (1) and the mixture was stirred for 72h at 23°C. All the 
attempts are summarized in Table 1, leading to some interesting remarks and 
conclusions for this synthesis. 
 For further examination of the optimal conditions, the environmental conditions 
were then modified, namely the temperature and the reaction time. The starting material 
was once again I3A (1) and the reagents the same as the ones referred to entry 1 of 
Table 1. These experiments are listed in Table 2. 
 
Investigation of the reaction mechanism 
 To explore the mechanism of the reaction and its’ potentials, we then applied 
the reaction on compounds that bear longer chains in the position 3 of the indolic 
scaffold (e.g. tryptophan and tryptamine). Moreover, aiming to examine the necessity 
and the nature of the nitrogen atom in position 1 of the arom tic core, we used 
benzo[b]thiophene and N-Boc-indolo-3-carbaldehyde as staring materials. In all cases 
the aforementioned developed protocol was applied. 
 
General protocol for the synthesis of compounds 2-2h and 3-3h 
A quantity (0.4 mmol) of the appropriately substituted indolic compound was 
added to a mixture of 2.1 mL H2O2 6% and 0.7 mL acetonitrile containing a catalytic 




72h at 23°C. The produced precipitate was filtered, washed with water, then solubilized 
with THF, collected and evaporated to dryness. 
The isolation of the synthesized compounds was performed with preparative TLC 
and their structure elucidation with NMR Spectroscopy. The synthesized compounds 
and the reaction yields are presented in Tables 3 and 4. 
Synthesis of indirubin (2) and tryptanthrin (3): 
The general method was followed using as starting material either I3A (1) or indole 
(8). In both cases the produced alkaloids and their yields were equivalent.  
Indirubin (2) 
Purple solid; Yield: 5%; Rf=0.50 (cyclohexane:EtOAc – 1:1 + 1.5% acetic acid). 
Spectral data are in accordance to Adachi et al.12 nd are given in Supporting 
Information. 
Tryptanthrin (3) 
Yellow solid; Yield: 12%; Rf=0.63 (cyclohexane:EtOAc – 1:1 + 1.5% acetic acid). 
Spectral data are in accordance to Jao et al.13 and are given in Supporting Information. 
Synthesis of 5,5’-difluoroindirubin (2a) and 2,8-difluorotryptanthrin (3a):  
The general method was followed using as starting material the 5-fluoroindole.  
5,5’-difluoroindirubin (2a) 
Purple solid; Yield: 5%; Rf=0.18 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid. 
Spectral data are in accordance to Wang et al.14 nd are given in Supporting 
Information. 
2,8-difluorotryptanthrin (3a) 
Yellow solid; Yield: 16%; Rf=0.53 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid). 
Spectral data are in accordance to Wang et al.15 nd are given in Supporting 
Information. 
Synthesis of 5,5’-dichloroindirubin (2b) and 2,8-dichlorotryptanthrin (3b): 
The general method was followed using as starting material the 5-chloroindole.  
5,5’-dichloroindirubin (2b) 
Purple solid; Yield: 5%; Rf=0.21 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid). 






Yellow solid; Yield: 10%; Rf=0.63 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid). 
Spectral data are in accordance to Wang et al.15 nd are given in Supporting 
Information. 
Synthesis of 5,5’-dibromoindirubin (2c) and 2,8-dibromotryptanthrin (3c): 
 The general method was followed using as starting material the 5-bromoindole.  
5,5’-dibromoindirubin (2c) 
Purple solid; Yield: 6%; Rf=0.44 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid). 
Spectral data are in accordance to Beauchard et al.17 and are given in Supporting 
Information. 
2,8-dibromotryptanthrin (3c) 
Yellow solid; Yield: 12%; Rf=0.64 (cyclohexane:EtOAc – 7:3 + 1.5% acetic 
acid). Spectral data are in accordance to Wang et al.15 and are given in Supporting 
Information. 
Synthesis of 5,5’-dimethylindirubin (2d) and 2,8-dimethylotryptanthrin (3d): 
The general method was followed using as starting material the 5-methylindole.  
5,5’-dimethylindirubin (2d) 
 Purple solid; Yield: 6%; Rf=0.23 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid 
Spectral data are in accordance to Wang et al.14 nd are given in Supporting 
Information. 
2,8-dimethylotryptanthrin (3d) 
Yellow solid; Yield: 15%; Rf=0.46 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid). 
Spectral data are in accordance to Wang et al.15 nd are given in Supporting 
Information. 
Synthesis of 5,5’-dicarbomethylindirubin (2e) and 2,8-
dicarboxymethylotryptanthrin (3e): 
The general method was followed using as starting material the 5-carboxymethylindole.  
5,5’-dicarboxymethylindirubin (2e)  
Red solid; Yield: 17%; Rf=0.27 (cyclohexane:EtOAc – 1:1 + 1.5% acetic acid). 
1H-NMR ((CD3)2SO, 600MHz): h 11.44 (brs, -NH); 11.34 (brs, -NH); 9.45 (d, H-4, 
J=1.7Hz); 8.18 (brs, H-4’); 8.16 (dd, H-6’, J=8.5Hz, 1.6Hz); 7.93 (dd, H-6, J=8.2Hz, 
1.7Hz); 7.54 (d, H-7’, J=8.5Hz); 7.02 (d, H-7, J=8.2Hz); 3.88 (s, 3H, -CH3); 3.86 (s, 





Yellow solid; Yield: 27%; Rf=0.52 (cyclohexane:EtOAc – 1:1 + 1.5% acetic acid). 
1H-NMR (CDCl3, 600MHz): h 9.11 (d, H-1, J=1.8Hz); 8.73 (d, H-10, J=8.4Hz); 8.59 
(d, H-7, J=1.4Hz); 8.51 (dd, H-3, J=8.4Hz, 1.8Hz); 8.49 (dd, H-9, J=8.4Hz, 1.4Hz); 
8.10 (d, H-4, J=8.4Hz); 4.02 (s, 3H, -CH3); 3.99 (s, 3H, -CH3) 
Synthesis of 6,6’-dibromoindirubin (2f) and 3,9-dibromotryptanthrin (3f):  
The general method was followed using as starting material the 6-bromoindole-3-
carbaldehyde.  
6,6’-dibromoindirubin (2f)  
Red solid; Yield: 5%; Rf=0.28 (cyclohexane:EtOAc – 7:3 + 1.5% acetic acid). 
Spectral data are in accordance to Clark et Cooksey18 and are given in Supporting 
Information. 
3,9-dibromotryptanthrin (3f)  
Yellow solid; Yield: 13%; Rf=0.65 (cyclohexane:EtOAc – 7:3 + 1.5% acetic 
acid). 1H-NMR (CDCl3, 600MHz): h 8.84 (d, H-10, J=1.6Hz); 8.28 (d, H-1, J=8.5Hz); 
8.19 (d, H-4, J=1.8Hz); 7.80 (dd, H-2, J=8.5Hz, 1.8Hz); 7.70 (d, H-7, J=8.1Hz); 7.61 
(dd, H-8, J=8.1Hz, 1.6Hz) 
Synthesis of 6,6’-dicarbomethylindirubin (2g) and 3,9-
dicarboxymethylotryptanthrin (3g): 
The general method was followed using as starting material the 6-carboxymethylindole.  
6,6’-dicarboxymethylindirubin (2g) 
Purple solid; Yield: 14%; Rf=0.40 (cyclohexane:EtOAc – 1:1 + 1.5% acetic 
acid). 1H-NMR ((CD3)2SO, 600MHz): h 11.45 (brs, -NH); 11.08 (brs, -NH); 8.82 (d, 
H-4, J=8.2Hz); 8.06 (brs, H-7’); 7.79 (d, H-4’, J=8.0Hz); 7.67 (d, H-5’, J=8.0Hz); 7.60 
(d, H-5, J=8.2Hz); 7.43 (brs, H-7); 3.90 (s, 3H, -CH3); 3.86 (s, 3H, -CH3) 
3,9-dicarboxymethylotryptanthrin (3g) 
Yellow solid; Yield: 17%; Rf=0.59 (cyclohexane:EtOAc – 1:1 + 1.5% acetic 
acid). Spectral data are in accordance to Wang et al.15 and are given in Supporting 
Information. 
Synthesis of 6’-bromoindirubin (2h) and 3-bromotryptanthrin (3h):  
The general method was followed using as starting material equivalent quantities of 






Purple solid; Yield: 5%; Rf=0.38 (cyclohexane:EtOAc – 7:3). Spectral data are 
in accordance to Clark et Cooksey18 and are given in Supporting Information. 
3-bromotryptanthrin (3h) 
Yellow solid; Yield: 12%; Rf=0.53 (cyclohexane:EtOAc – 7:3). Spectral data 
are in accordance to Li et al.19 and are given in Supporting Information. 
 
Calculation of the reaction yields with NMR Spectroscopy 
The calculation of the reaction yields was performed using quantitative 1H-
NMR spectroscopy in a similar way as previously described for metabolite quantitation 
in complex natural mixtures.20  The spectra were acquired in solution of the reaction 
mixtures after the work up described above at specific concentratio  in (CD3)2SO, 
where a known quantity of syringaldehyde was added as Internal Standard. Using the 
peak of the aldehyde group of syringaldehyde at 9.79 ppm for comparison, the ratio of 
the reactants/products was measured in the reaction mixture. 
 
Protocol for the evaluation of AhR activity 
The synthesized alkaloids were evaluated for their ability to activate AhR-
dependent gene expression in two different recombinant cell lin s (human hepatoma 
(HG2L7.5c1) and mouse hepatoma (H1L7.5c3),) containing the identical stab y 
transfected AhR-responsive luciferase reporter gene plasmid, pGudLuc7.5.21, 22 The 
results (EC50 (M)) calculated from concentration-response experiments were compared 
to those of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the prototypical and highly 
potent AhR agonist. The AhR activity protocol was derived from He et al.23 and was as 
follows:  
Human and mouse cell lines were grown in 100-mm tissue culture plates 
(Corning Glass Works; Corning, NY) using sterile techniques, maintained in culture 
medium (alpha-minimum essential media (g-MEM) supplemented with 10% (v/v) fetal 
bovine serum (FBS) and G418 (1 mg/mL)) and incubated at >80% humidity an  37°C.  
For AhR-dependent gene expression analysis, plates of human or mouse cells 
(approximately 80–100% confluent) were trypsinized and resuspended in 20 mL 
culture media. An aliquot (100 たL) of the indicated cell suspension was added into 
sterile 96-well tissue culture plates (Corning) and plates w re incubated for 24 h prior 
to chemical exposure, allowing cells to attach and reach confluence. Prior to ligand 




were incubated with culture media containing DMSO (10 たL/mL) or the indicated 
concentration of TCDD or test compounds in DMSO for 6h or 24h at 37°C. For AhR 
antagonist studies, cells were incubated with TCDD or 3-bromotryptanthrin in the 
absence or presence of the indicated concentration of the AhR antagonist CH223191 
(Chembridge Corporation; San Diego, CA) or StemRegenin1 (SR1) (Cayman 
Chemicals; Ann Arbor, MI)) for 6h at 37°C. 
After incubation cells were washed twice with PBS, 100 たL of 1X Lysis buffer 
(Promega; Madison, WI) was added to each well and the plate shaken at room 
temperature until cells were lysed (approximately 20 min). Luciferase activity was 
measured using an automated microplate luminometer (Anthos Lucy2, Austria) in 




Initial methodology of the reaction on I3A (1) 
The performance of the initial reaction led to the formation and isolation of 
indirubin (2) after treatment of I3A (1) with H2O2 under Baeyer-Villiger oxidation 
conditions (Figure 1). However, several practical difficulties were observed in the 
above reaction such as the need for renewal of the reag nts in the course of the reaction 
or the way of evaluating its success. Therefore, we investigated the possible 
ameliorations that could increase the reaction yield. 
 
Modification of the reaction and application on I3A (1) and indole (8) 
A reaction described by Santoro et al.11 was selected as alternative synthetic 
approach. It seemed preferable mainly due to its reagents, which ere coinciding with 
the ones used for the transformation of I3A (1) to indirubin (2). According to this 
protocol, H2O2 has to be at a concentration of 6%, the solvent H2O:ACN in a ratio 3:1 
and the optimal conditions are achieved when the selenium derivative is added in a 
catalytic amount (10%) and the reaction mixture is stirred for 72h at 23°C. This 
synthetic path is being characterized as an “eco-friendly olefin dihydroxylation”, 
probably due to the eco-friendly reagents used, and is proposed for the formation of vic 
diols (cis- or trans-) from the corresponding alkenes. 
When the above conditions were applied on I3A (1), they resulted once again 




fluorescent yellow compound was predominant. The yellow compound was isolated 
and identified as indolo[2,1-b]quinazolin-6,12-dione or tryptanthrin (3) after 
comparison of its spectroscopic data with literature13. Tryptanthrin (3) is an already 
known AhR inducer which possesses also significant anti-inflammtory, antimicrobial 
and cytostatic activity.24-30 It has been isolated from many plants as well as the yeast 
Candida (Yarrowia) lipolytica31-33 and has also been detected and isolated in 
Malassezia furfur yeasts.3, 4 Additionally, the spectroscopic analysis of the mixture 
showed the formation of indolo[3,2-b]carbazole (4), another known Malassezia 
metabolite, in traces (Figure 2). 
Those results prompted us to investigate further the optimal conditions for the 
reaction as well as its mechanism. During this effort, the reaction was also applied on 
simple indole (8), another abundant metabolite of Malassezia spp. 5 and interestingly 
the formation of the metabolites 2 and 3 was also achieved, while indolo[3,2-
b]carbazole (4) was not detected. 
 
Optimization of the reaction conditions 
The successful application of the oxidation on indole (8) and I3A (1) paved the 
road for a further investigation of the optimal reaction conditions as well as for the role 
of each reagent. For this reason, several trials were p formed and the attempts are 
summarized in Table 1. Further details on the optimization of the reaction c ditions 
are presented as supporting information. 
  
Synthesis of tryptanthrin and indirubin derivatives 
After the described synthesis was successfully applied on indole (8) and I3A (1) 
and the optimal reaction conditions were clarified, the next step was the application on 
substituted indoles and indole-3-carbaldehydes. A wide variety of substituted indole 
compounds bearing halogens, alkyl-, hydroxyl-, alkoxy-, carboxymethyl- and amino- 
groups in positions 4, 5, 6 or 7 of the indole ring was chosen to be studied. 
The most active among them seemed to be the compounds with ubstituents in 
positions 5 or 6 of the core and, especially, the ones that bore halogens, alkyl- and 
carboxymethyl- groups. This observation let us proceed in the synthesis of all the 
corresponding bisubstituted indirubins and tryptanthrins in yields that varied from 5 to 
17% for indirubins (2-2g) and from 10 to 27% for tryptanthrins (3-3g), depending on 




carboxymethylindoles were used as reactants. On the contrary, the application of this 
protocol on indoles bearing easily oxidizable groups (e.g. amino-, cyano-, hydroxyl- or 
methoxy- groups), led to the formation of dark colored, non-soluble precipitates. 
Furthermore, the reaction didn’t evolve as predicted when applied on either azaindoles 
or compounds with substituents in positions 4 or 7 of the indolic core. 
Yet, another reaction performed on the mixture of I3A (1) and 6-bromo-I3A 
resulted in the simultaneous synthesis of all 8 bis-, mono- and unsubstituted analogues 
of the two alkaloids. Amongst the monosubstituted compounds, the formation of 6’-
bromoindirubin and 3-bromotryptanthrin was favored by thereaction conditions, 
probably due to differences in the kinetics of the reactions. 
 
Evaluation of AhR Agonist Activity 
The AhR agonist activity of 15 out of the 18 synthesized compounds was 
evaluated in recombinant HG2L7.5c1 human hepatoma cells containing a stably 
transfected AhR-responsive luciferase reporter gene.22 Indirubins were tested only in 
the human cell line due to previous evidence for the high selectivity of indirubins for 
the human AhR as compared to the mouse AhR.3, 34, 35 In contrast, tryptanthrin 
analogues were tested in both stably transfected human  (HG2L7.5c1) and mouse 
(H1L7.5c3)hepatoma cell lines, not only to determine their relativ  potencies and 
efficacies, but also to evaluate whether these analogues also exhibited a greater 
selectivity for human AhR compared to mouse AhR. The 6 hour concentration-response 
results of tryptanthrins obtained using the human HG2L7.5c1 cells are presented in 
Figure 3. The EC50 (M) results from concentration response curve for the indirubins 
and tryptanthrins were calculated and compared to the EC50 (M)  obtained from TCDD 
concentration response analysis (Tables 5 and 6). 
While most of the synthesized indirubins showed very strong activity (two of 
them (2b, 2f) had potencies comparable to or greater than TCDD), insertion of 
substituents reduced activity in comparison to the highly potent unsubstituted indirubin 
(Table 5). Concerning the tryptanthrin analogues, it is clear that this skeleton can afford 
extremely active derivatives with very simple modifications. 
Among the tryptanthrin derivatives (Table 6), 3,9-dibromotryptanthrin (3f) 
interestingly showed a 350-fold increased potency compared to tryptanthrin (3) in the 
human HG2L7.5c1 cells and was comparable to the potency of TCDD when evaluated 




bromotryptanthrin) was 3,000-times more potent than tryptanthrin and 10 times more 
potent than TCDD in the human cells. Given the previously documented high degree 
of selectivity of indirubin for human AhR, as compared to mouse AhR,3, 34, 35 and 
similarities in several structural aspects of indirubin and tryptanthrin, the relative 
potencies of tryptanthrin analogues in human and mouse cells w re compared.  These 
analyses revealed that while most tryptanthrin analogues were about 10-fold less potent 
in the mouse cell line, as compared to that of the human cell line, all were significantly 
less potent than TCDD in the mouse cells (Table 6, Figure 4).   Interesting, 3,9-
dibromotryptanthrin and 3-bromotryptanthrin were 4,000- and 10,000-fold less potent 
in the mouse cells, respectively, than in the human cells, where these compounds were 
equipotent to or more potent than TCDD (Table 6, Figure 4).  These results clearly 
demonstrate that 3,9-dibromotryptanthrin and 3-bromotryptanthrin are highly potent 
and efficacious human selective AhR agonists.  
To confirm that the induction of reporter gene expression in human cells was 
mediated by the AhR, the effect of AhR antagonists (CH223191 and SR136, 37 on the 
induction of reporter gene expression by 3-bromotryptanthrin was examined in the 
human HG2L7.5c1 cells (Figure 4).  These results clearly demonstrate that AhR 
antagonists inhibit both TCDD- and 3-bromotryptanthrin-dependent reporter gene 
induction in the human cell line, consistent with these reponses being mediated by the 
AhR 
The gene induction experiments were carried out at 6h of incubation due to the 
metabolic lability of the tryptanthrins.   
At 24h of incubation, the EC50 for gene induction in human cells by TCDD 
remained as low as 3x10-10 M but the potency of tryptanthrins was significantly reduced 
(EC50s of 10-6 to 10-7) and this results from differences in the metabolism of these 
compounds. While TCDD cannot be metabolized to any significant degree and 
therefore its relative potency is retained at 24h, tryptanthrins are metabolized by the 
CYP enzymes induced in these cells, resulting in induction of AhR-dependent gene 
expression that is transient, with a maximum peak between 6h and 12h. 
 
Discussion 
Here we describe the one-step transformation of the aldehyde 1 and/or indole 





As already analyzed, the established reaction protocol is the result of an amelioration 
process, with one of the most important and consistent characteristics to be the catalyst 
used, diphenyl diselenide, the reaction of which with H2O2 results in the in situ 
formation of the corresponding seleninic acid (aka Syper method of activation).38-40 The 
necessity for further investigation and optimization of the procedure led us to perform 
an extensive bibliographic search on oxidation of indoles and on reactions using either 
H2O2 as an oxidative means or organic derivatives of selenium as a catalyst, identified 
a number of different relevant publications41-51.  
 We chose to follow the procedure as it is described by Santoro et al.11 as it 
combined the use of H2O2 and diphenyl diselenide with  the organoselenic derivatives 
to be a category of catalysts preferred in several organic reactions due to their easy 
synthesis and their stability under various conditions.52 Throughout this protocol, we 
achieved the one-step transformation of the aldehyde 1 to the alkaloids 2 and 3 in good 
yields and the compound 4 in traces. This can be considered as a biomimetic reaction, 
showing for the first time the possible common biosynthetic origin of the three 
metabolites (Figure 2), assumption that is verified by the synthesis of the same two out 
of three alkaloids when indole (8), also a metabolite found in abundance in Malassezia 
cultures, was used as starting material. The one-pot conversion of both I3A (1) and 
indole (8) to indirubin (2) and tryptanthrin (3) simultaneously via the same oxidative 
reaction has never been reported. 
The up-to-date data on the oxidation of indoles refer to studies conducted in 
many different ways, using a variety of reagents (usually expensive and difficult to 
handle) and leading mainly to the formation of the corresponding 2-indolinones or 
oxindoles.41, 42, 45-47 In some cases also indigo48, 49 or isatin were formed.50 Additional 
research on the attempted syntheses of the two alkaloids revealed that both are formed 
by the coupling of an isatin (5) molecule with either 3-acetoxyindole for indirubin (2)53 
or isatoic anhydride for tryptanthrin (3).31, 54, 55 Many other alternative paths have been 
used for the synthesis of 3, including even electrochemical methods and condensation 
of isatin (5).31, 56-60 A review on the synthetic and medicinal advances for tryptanthrin 
has been recently published, summarizing most of the available methods for 
tryptanthrin synthesis.61 Among the most recent publications, some newer interesting 
methods for the synthesis of thryptanthrin (3) were described that are very similar to 
the aforementioned biomimetic reaction. In two of them, I3A (1) was submitted to 




peroxide in toluene.63 Especially the last one is very efficient for tryptanthrin but not 
for indirubin and probably this is related with the use of toluene and heat that make the 
reaction conditions much more different than those used in our case which are closer to 
those of a living organism (aqueous medium and ambient temperature). Three more 
publications have used indole (8) as starting material which is dimerized either with 
copper iodide as a catalyst under a continuous flux of oxygen15 or via irradiation by 
LED light combined with the use of selected catalysts and simultaneous exposure to 
oxygen.19, 64  
However, the developed synthetic protocol followed in our caseseems to have 
certain advantages. This synthetic path is being described as an “eco-friendly olefin 
dihydroxylation” leading to the formation of vic diols from the corresponding alkenes.11 
The eco-friendly character of the reaction is of great importance and reassured by the 
solvents (water and ACN) and the reagents (H2O2 and (PhSe)2  used, that are not 
harmful for the environment, especially after the treatmnt of the residue. Other 
advantages are the simple overall procedure, th  low-cost, easily accessible reagents 
and the possibility of application on a significant number of substrates, comprising both 
indoles and indole-3-carbaldehydes. All these features, along with the simultaneous 
formation of two different categories of alkaloids, establish the reaction as an attractive 
alternative for their synthesis. To the very best of our knowledge, the successful 
application of the same dimerization reaction on both indole (8) and I3A (1) hasn’t been 
reported before whereas the parallel synthesis of both indirubin (2) and tryptanthrin (3) 
has been mentioned only once again,62 where indirubin (2) is referred to as one of the 
byproducts of the reaction. 
The mechanism that mediates the oxidative transformation of I3A (1) and indole 
(8) is difficult to be confirmed with certainty. A primary concept can be based on the 
mechanism described by Santoro, involving the formation of an intermediary epoxide 
which then opens to the cis- or trans- diol11 and the catalyst is reborn through this cycle. 
In accordance to the above assumption, we came up with a hypothesis involving 
the synthesis of 3-indolyl formate (5), which would be originally expected under Bayer-
Villiger conditions, and the subsequent formation of an intermediary epoxide on the 
double bond of the positions 2 and 3. Hydrolysis of the intermediate results in isatin 
(6), creating thus an equilibrium between the indole derivatives 5 and 6, the coupling 




well-known methodology of indirubin (3) synthesis53 which involves a coupling 
reaction between 3-acetoxyindole and isatin (6). 
A quite similar mechanism is proposed for the synthesis of tryptanthrin (3) 
which is thought to be produced by the coupling reaction between anthranilic acid (7) 
and isatin (6). As mentioned, isatin (6) is formed in the reaction medium, whereas 
anthranilic acid (7) can result by the hyperoxidation of either I3A (1) or isatin (6) and 
subsequent in situ formation of the isatoic anhydride which will be hydrolyzed to yield 
the acid 7, a hypothesis supported by previous bibliographic data.60 This synthetic path 
is shown in Figure 6 and the concept behind this proposed mechanism is similar to the 
ones suggested by the most relevant publications.15, 62, 63 
It’s worth mentioning that, like in the case of indirubin (2), the reaction between 
anthranilic acid (7) and isatin (6) is a common synthetic method for the production of 
tryptanthrin (3),65, 66 with distinct reference to the biosynthesis of the alkaloid.31 
However, when an ACN solution of the proposed intermediates isatin (6) and 
anthranilic acid (7) was stirred for 72h at 23°C none of the desirable alkaloids were 
formed, suggesting the necessity of an oxidative means in the reaction medium, an 
assumption that is also in accordance with bibliographic data.60, 65, 66 
The aforementioned synthetic schemes represent largely the assumed 
mechanisms for the transformation of indole (8) to the two alkaloids when the exact 
same reaction conditions. The hypothesis is slightly altered, involving the condensation 
of two molecules of the produced isatin (6). This is supported also by recent data that 
describe the synthesis of indirubins by isatin coupling in reductive conditions.14 The 
proposed synthetic scheme for this reaction is in Figure 7. 
As far as the formation of indolo[3,2-b]carbazole (4) is concerned, a different 
mechanism is proposed, involving the direct coupling of two I3A (1) units (Figure 8) 
and is based on relevant bibliographic data.9, 67-70 As it has already been mentioned, 
compound 4 is formed only in the reaction of I3A (1). This observation can be easily 
explained as indolo[3,2-b]carbazole (4) is a molecule with 18 carbon atoms whilst the 
dimerization of indole (8), can offer only up to 16 carbon atoms in the reaction. On the 
other hand, in the reaction of I3A (1) the carbon atoms participating are sufficient 
enough for the formation indolo[3,2-b]carbazole (4).
Summing up the details of the reaction mechanism, we need to state the 
importance of the order of addition of the reagents as, according to the general reaction 




of the oxidative means with the catalyst has to take place prior to its reaction with the 
starting material. For this reason, the addition of H2O2 in the solution of the catalyst 
before the reactant is mandatory. 
Finally, examining the products resulting from the reaction on the mixture of 
I3A (1) and 6-bromo-I3A (8) we observed the favored synthesis of certain compounds; 
combined with the mechanisms proposed, they can lead to some re arks for the 
kinetics of the transformations. Given the bibliographic data31, 71 the 6’-substitution on 
indirubin scaffold derives from the substitution of acetoxyindole and, respectively, the 
3-subsitution on tryptanthrin from the anthranilic acid (7). Our observation can suggest 
that the reaction for the formation of 6-bromoisatin (10) progresses more slowly than 
the corresponding acetoxyindole (9) and anthranilic acid (11), favoring thus the one for 
the non-acylated compound (Figure 9). According to this hypothesis, the synthesis of 
6’-bromoindirubin (2h) and 3-bromotryptanthrin (3h) seems to be favored compared to 
the 6- and 9- substituted compounds. 
The final step of this work comprised the evaluation of the AhR agonist activity 
of the purified indirubin and tryptanthrin analogues and revealed some interesting 
results for these classes of alkaloids. Although most of the synthesized indirubin 
analogues were relatively potent AhR agonists, all of the resulting compounds were 
less potent than that of unsubstituted indirubin. Additionally, it was clear that even 
simple modification of the tryptanthrin skeleton could produce analogues that are 
extremely potent and efficacious AhR agonists, particularly in the human cell line. 
The tryptanthrin structure activity relationship bioassay results in human cells 
revealed that insertion of bromine at positions 3 and 9 (3f) not only increased the 
relative potency (EC50) of unsubstituted tryptanthrin (3) from 170 nM to 490 pM, but 
induced maximal AhR-dependent reporter gene activity (Figure 3).  These observations 
are significant in that the relative potency and efficacy of the 3,9-dibromotryptanthrin 
as an AhR agonist in human cells is comparable to that of TCDD, the prototypical and 
one of the most potent known AhR agonists.  Even more significant is that a tryptanthrin 
analogue with only a single bromine at position 3 (3-bromotryptanthrin (3h)) had a 
relative potency in human cells that was even 10-fold higher (57 pM), not only 
suggesting that the additional bromine at position 9 in compound 3f actually reduced 
the overall relative AhR affinity/potency compared to that of compound 3h, but 
producing a compound that was 10-fold more potent than TCDD.  3-Bromotryptanthrin 




reporter gene expression to a level comparable to that produced by a maximally 
inducing concentration of TCDD (Figure 3).  Previous mutagenesis and molecular 
docking analysis studies have clearly demonstrated that some pecific interactions of a 
ligand with residues within the AhR ligand binding site are critical and can drive ligand-
selective interactions,72-75 such that a simple modification like the insertion of a 
carbomethoxy group in the same scaffold positions (3g) instead of bromine can lead to 
a completely inactive derivative.  While induction of reporter gene expression in the 
human cells by a given compound strongly suggests that it is an AhR agonist and 
activates reporter gene expression via the AhR, the role of the AhR in the ability of the 
most potent tryptanthrin analogue (3-bromotryptanthrin (3h)) was confirmed by 
demonstrating the ability of two AhR antagonists (CH223191 and SR1) to inhibit the 
induction response (Figure 4).  Together, these analyses hav identified two new and 
novel tryptanthrin analogues (3-bromotryptanthrin and 3,9-dibromotryptanthrin) as 
highly potent and efficacious agonists of the human AhR and AhR signaling pathway.      
Studies from several laboratories have demonstrated that indirubin is a highly 
potent and efficacious human-selective AhR agonist that induces AhR-dependent gene 
expression in human cells with an EC50 that is ~10-fold greater than that of TCDD.3, 34, 
35, 76 In contrast, in mice or mouse cells, indirubin is ~100-less s potent than TCDD, 
but still highly efficacious.34, 35, 76 Site-directed mutagenesis and functional analysis 
studies have identified specific amino acid residues within the mouse and human AhR 
ligand binding pockets that contributes to this differential specificity and 
responsiveness.35 The similarities in structual aspects of indirubins and tryptanthrins 
suggest that similar species differences in tryptanthrin ligand specificity may also exist.  
Comparison of the relative potencies of the indirubins (3-3h) to stimulate AhR-
dependent reporter gene analysis in both human and mouse hepatoma cell lines 
containing the identical reporter gene plasmid (Table 6) reveal d that while the potency 
of tryptanthrin (3) was comparable between human and mouse cell lines, all tryptanthrin 
analogues were less potent in the mouse cell lines. The divergent species-specificity 
was particularly evident for the tryptanthin analogues that were most potent human 
AhR agonists (i.e., 3-bromotryptanthrin (3h) and 3,9-dibromotryptanthrin (3f)). While 
3-bromotryptanthrin (3h) was 10-times more potent than TCDD in human cells, it was 
10,000-times less potent than TCDD in the mouse cells; the difference in relative AhR 
agonist potency between the human and mouse cells was >17,000-fold (Table 6).  




human cells, it was 4,000-times less potent than TCDD in the mouse cells; the 
difference in relative AhR agonist potency between the human and mouse cells was 
~800-fold (Table 6). These results confirm that these two tryptanthrin analogues, like 
indirubin, are human-selective AhR agonists. However, the AhR antagonist results with 
3-bromotryptanthrin suggest that it interacts with residues within the AhR ligand 
binding pocket in a manner that is distinctly different than that of indirubin.  Previous 
studies have demonstrated that while the AhR antagonist CH223191 could effectively 
inhibit the ability of TCDD to bind to and activate the AhR, this antagonist had little 
effect on AhR activation by indirubin,37 suggesting that TCDD and indirubin 
differentially interact with residues within the AhR ligand binding domain. The ability 
of CH223191 to inhibit AhR-dependent reporter gene activity by both TCDD and 3-
bromotryptanthrin (Figure 5) suggests that binding of 3-bromotryptanthrin to the AhR 
is more similar to that of TCDD than indirubin, which is not inhibited by CH223191.  
However, since 3-bromotryptanthrin is a more potent AhR activator of the human AhR 
than TCDD and a much less potent activator of the mouse AhR than TCDD, 3-
bromotryptanthrin must interact with the AhR ligand bidning pocket in a manner 
similar to, but distinctly different from that of TCDD; the differences in potency of 
TCDD between the human and mouse cell lines was only ~6-fold (Table 6).  These 
induction and inhibition responses suggest that 3-bromotryptanthrin (and perhaps other 
tryptanthrins) may represent a novel group of AhR agonists that interact with residues 
within the AhR ligand binding pocket in a manner distinctly different from TCDD, 
indirubin and other ligands characterized to date.34, 35, 73-77  However, further detailed 
QSAR and docking analysis of these analogues into both human and mouse AhR ligand 
binding sites generated by molecular modeling are needed to understa  the molecular 
mechanisms responsible for the high affinity/potency of select d tryptanthrins and the 
dramatic species differences in ligand specificity.    
 
Conclusion 
The total of the collected data is of significant chemical and toxicological value. 
The synthesis of all three alkaloids -indirubin (2), tryptanthrin (3) and indolo[3,2-
b]carbazole (4)- through the same oxidative mechanism from I3A (1), the main product 
of L-tryptophan metabolism in Malassezia yeasts, seems to be used also by the fungus 
for the production of these secondary metabolites which are implicated in the 




tryptanthrin (3) are often together isolated from several plant species, like Isatis spp. 
and Polygonum tinctorium,78, 79 the existence of a common biosynthetic path for the 
two metabolites is a reasonable hypothesis. The inhibition of the oxidative 
transformation of I3A to indirubin and tryptanthrin by Malassezia could be a potential 
future target for the inhibition of Malassezia toxicity to skin. 
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AhR: Aryl-hydrocarbon Receptor 
I3A: Indole-3-carbaldehyde 
H2O2: Hydrogen Peroxide 
ICZ: Indolo[3,2-b]carbazole  
6-FICZ: 6-Formylindolo[3,2-b]carbazole 
NMR: Nuclear Magnetic Resonance 
TLC: Thin Layer Chromatography 
DCM: Dichrolomethane 
(PhSe)2: Diphenyl diselenide 
THF: Tetrahydrofuran 
Rf: Retardation factor 
EtOAc: Ethyl Acetate 
(CD3)2SO: Deuterated Dimethyl Sulfoxide 
CDCl3: Deuterated Chloroform 





g-MEM: alpha-minimum essential media  
FBS: Fetal bovine serum  
PBS: phosphate-buffered saline 
DMSO: Dimethyl Sulfoxide 
ACN: Acetonitrile 












1 H2O2 6% (PhSe)2 10% ACN Indirubin&Tryptanthrin 
2 H2O2 6% (PhSe)2 10% - Hyperoxidation 
3 H2O2 6% - - ACN n.d. 
4 H2O2 6% (PhSe)2 20% ACN Indirubin&Tryptanthrin 
5 H2O2 6% (PhSe)2 50% ACN Indirubin&Tryptanthrin 
6 H2O212% (PhSe)2 10% ACN Indirubin&Tryptanthrin 
7 H2O212% (PhSe)2 10% - Hyperoxidation 
8 H2O212% - - ACN n.d. 
9 H2O212% (PhSe)2 20% ACN Indirubin&Tryptanthrin 
10 H2O212% (PhSe)2 50% ACN Indirubin&Tryptanthrin 
n.d.: not detected 
 
Table 2: Trials of the biomimetic reaction with modification of the conditions 
Entry Temperature Reaction 
Time 
Result 
11 0-23°C 72h Indirubin&Tryptanthrin 
12 ~10°C 72h Lower yield 
13 40°C 72h Lower yield 

































2 R5=R6=R5’=R6’=H 5% 
2a R5=R5’=F, R6=R6’=H 5% 
2b R5=R5’=Cl, R6=R6’=H 5% 
2c R5=R5’=Br, R6=R6’=H 6% 
2d R5=R5’=CH3, R6=R6’=H 6% 
2e R5=R5’=COOCH3, R6=R6’=H 17% 
2f R5=R5’=H, R6=R6’=Br 5% 
2g R5=R5’=H, R6=R6’=COOCH3 14% 
2h R5=R5’= R6=H, R6’=Br 5% 
 
Substitution Yield 
3 R2=R3=R8=R9=H 12% 
3a R2=R8=F, R3=R9=H 16% 
3b R2=R8=Cl, R3=R9=H 10% 
3c R2=R8=Br, R3=R9=H 12% 
3d R2=R8=CH3, R3=R9=H 15% 
3e R2=R8=COOCH3, R3=R9=H 27% 
3f R2=R8=H, R3=R9=Br 13% 
3g R2=R8=H, R3=R9=COOCH3 18% 




Table 5: EC50values for the induction of AhR-dependent gene expression in human hepatoma 











Table 6: EC50values for the induction of AhR-dependent gene expression in human 



















3 1.7x10-7 8.1x10-7 
3a 5.4x10-8 2.0x10-6 
3b 8.4x10-8 9.1x10-7 
3c 5.6x10-7 3.6x10-6 
3d 6.8x10-8 7.2x10-7 
3e 4.5x10-7 3.7x10-6 
3f 4.9x10-10 3.9x10-7 
3g Inactive Inactive 
3h 5.7x10-11 >1.0x10-6 
























Figure 3: Concentration-response analysis of the induction of AhR-dependent luciferase 
reporter gene expression in human hepatoma (HG2L7.5c1) cells by TCDD, tryptanthrin and 




















Figure 4: The AhR antagonists CH223191 (CH) and StemRegenin1 (SR1) inhibit TCDD- 
and 3BT (3h)-dependent induction of luciferase reporter gene expression in recombinant 
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(64) Zhang, C., Li, S., Burě, F., Lee, R., Ye, X. and Jiang, Z. (2016) Visible Light 
Photocatalytic Aerobic Oxygenation of Indoles and pH as a Chemoselective 
Switch. ACS Catal. 6, 6853-6860. 
(65) Jahng, K. C., Kim, S.I., Kim, D.H., Seo, C.S., Son, J.K., Lee, S.H., Lee, E.S. 
and Jahng, Y. (2008) One-pot synthesis of simple alkaloids: 2,3-Polymethylene-
4(3H)-quinazolinones, luotonin A, tryptanthrin, and rutaecarpine. Chem. 
Pharm. Bull. 56, 607-609. 
(66) Wang, C., Hou, B., Zhang, N., Sun Y. and Liu J. (2015) Biomimetic Synthesis 
of Natural Product Tryptanthrin and Its Derivatives. Chem. J. Chinese U. 36, 
274-278. 
(67) Bergman, J. (1970) Condensation of indole and formaldehyde in th  presence 
of air and sensitizers. Tetrahedron 26, 3353-3355. 
(68) Bergman, J., Carlsson, R., and Misztal, S. (1976) The reaction of some indoles 
and indolines with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. Acta Chem. 
Scand. 30b, 853−862. 
(69) Amat-Guerri, F., Martinez-Utrilla, and Pascual, C. (1984) Condensation of 3-
hydroxymethylindoles with 3-substituted indoles. Formation of 2,3ガ-
methylennediidole-derivatives. J. Chem. Res. Synop., 160−161. 
(70) Bandgar, B. P., and Shaikh, K.A. (2016) Molecular iodine-catalyzed efficient 
and highly rapid synthesis of bis(indolyl)methanes under mild conditions. 
Tetrahedron Lett. 44, 1959-1961. 
(71) Polychronopoulos, P., Magiatis, P., and Skaltsounis A.-L. (2004) Structural 
basis for the synthesis of indirubins as potent and selective inhibitors of 
Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases. J. Med. Ch m. 47, 
4. 
(72) Pandini, A., Soshilov, A.A., Song, Y., Zhao, J., Bonati, L. and Denison, M.S. . 
(2009) Detection of the TCDD binding fingerprint within the Ah receptor ligand 
binding domain by structurally driven mutagenesis and functional a ysis. 




(73) Motto, I., Bordogna, A., Soshilov, A., Denison, M.S. and Bonati, L. (2011) A 
new aryl hydrocarbon receptor homology model targeted to improve d cking 
reliability. J. Chem. Info. Modeling 51, 2868-2881. 
(74) Soshilov, A. A. a. D., M.S. (2014) Ligand promiscuity of aryl hydrocarbon 
receptor agonists and antagonists revealed by site directed mu agenesis. Molec. 
Cell. Biol. 34, 1707-1719. 
(75) Giani, T. S., Faber, S.C., Motta, S., Denison, M.S. and Bonati, L. (2018) 
Modeling the binding of diverse ligands within the Ah receptor ligand binding 
domain. Sci. Reports 9, 10693. 
(76) Flaveny, C. A. a. P., G.H. (2009) Transgenic human AhR mouse reveals 
differences between human and mouse AhR ligand selectivity. Molec. Cell. 
Pharmacol. 1, 119-123. 
(77) Fraccalvieri, D., Soshilov, A.A., Karchner, S.I., Franks, D.G., Pandini, A., 
Bonati, L., Hahn, M.E. and Denison, M.S. (2013) Comparative analysis of 
homology models of the Ah receptor ligand binding domain: Verification of 
structure-function predictions by site-directed mutagenesis of a non-functional 
AhR. Biochem. 52, 712-725. 
(78) Honda, G., Tosirisuk, V., and Tabata, M. (1980) Isolation of an 
antidermatophytic, tryptanthrin, from the indigo plants, Polygonum tinctorium 
and Isatis tinctoria. Planta Med. 38, 275-276. 
(79) Hoessel, R., Leclerc, S., Endicott, J.A., Nobel, M.E., Lawrie, A., Tunnah, P., 
Leost, M., Damiens, E., Marie, D., Marko, D., Niederberger, E., Tang, W., 
Eisenbrand, G., Meijer, L. (1999) Indirubin, the active constituent of a Chinese 
antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1, 
60-67. 
 
